DK1287134T3 - Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf - Google Patents

Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf

Info

Publication number
DK1287134T3
DK1287134T3 DK01946126T DK01946126T DK1287134T3 DK 1287134 T3 DK1287134 T3 DK 1287134T3 DK 01946126 T DK01946126 T DK 01946126T DK 01946126 T DK01946126 T DK 01946126T DK 1287134 T3 DK1287134 T3 DK 1287134T3
Authority
DK
Denmark
Prior art keywords
subunit
sodium channel
gated sodium
host cells
methods
Prior art date
Application number
DK01946126T
Other languages
Danish (da)
English (en)
Inventor
Ning Qin
Ellen Codd
Andrea Michael D
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1287134T3 publication Critical patent/DK1287134T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
DK01946126T 2000-06-07 2001-06-06 Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf DK1287134T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29440500P 2000-06-07 2000-06-07
US23666400P 2000-09-29 2000-09-29
PCT/US2001/018304 WO2001094414A2 (en) 2000-06-07 2001-06-06 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE

Publications (1)

Publication Number Publication Date
DK1287134T3 true DK1287134T3 (da) 2007-12-03

Family

ID=26929995

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01946126T DK1287134T3 (da) 2000-06-07 2001-06-06 Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf

Country Status (12)

Country Link
US (3) US6994993B2 (de)
EP (1) EP1287134B1 (de)
JP (1) JP2004514413A (de)
AT (1) ATE368740T1 (de)
AU (1) AU2001268212A1 (de)
CA (1) CA2411069A1 (de)
DE (1) DE60129688T2 (de)
DK (1) DK1287134T3 (de)
ES (1) ES2290149T3 (de)
MX (1) MXPA02012223A (de)
PT (1) PT1287134E (de)
WO (1) WO2001094414A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104455A1 (en) * 2002-06-07 2003-12-18 Sophion Bioscience A/S Screening methods
WO2004044205A1 (en) * 2002-11-11 2004-05-27 Korea Chungang Educational Foundation Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter
JP2006518625A (ja) * 2003-02-14 2006-08-17 サルヴィアック・リミテッド ステントデリバリ及び配置システム
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
MX2019011772A (es) 2017-04-03 2020-01-09 Encoded Therapeutics Inc Expresion transgenica selectiva de tejidos.
EP3717505A4 (de) 2017-12-01 2021-12-01 Encoded Therapeutics, Inc. Gentechnisch veränderte dna-bindende proteine
PL3976798T3 (pl) 2019-05-29 2026-04-07 Encoded Therapeutics, Inc. Kompozycje i sposoby selektywnej regulacji genów
CN114107323B (zh) * 2021-12-20 2023-04-28 青岛农业大学 KIbB1基因在植物抗逆性中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030810A (en) 1997-02-26 2000-02-29 Delgado; Stephen Gregory Cloned tetrodotoxin-sensitive sodium channel α-subunit and a splice variant thereof
WO2001023571A1 (en) 1999-09-30 2001-04-05 The Regents Of The University Of Michigan Methods and compositions relating to sodium channel beta1a subunits

Also Published As

Publication number Publication date
HK1054052A1 (en) 2003-11-14
US6994993B2 (en) 2006-02-07
EP1287134B1 (de) 2007-08-01
US7063953B2 (en) 2006-06-20
CA2411069A1 (en) 2001-12-13
DE60129688T2 (de) 2008-04-30
MXPA02012223A (es) 2004-08-19
US20020045229A1 (en) 2002-04-18
EP1287134A2 (de) 2003-03-05
ATE368740T1 (de) 2007-08-15
ES2290149T3 (es) 2008-02-16
US7408036B2 (en) 2008-08-05
US20060269996A1 (en) 2006-11-30
DE60129688D1 (de) 2007-09-13
AU2001268212A1 (en) 2001-12-17
PT1287134E (pt) 2007-10-04
WO2001094414A2 (en) 2001-12-13
WO2001094414A3 (en) 2002-06-06
JP2004514413A (ja) 2004-05-20
US20040002439A1 (en) 2004-01-01

Similar Documents

Publication Publication Date Title
AU2001278797A1 (en) Expression vector using for animal cell
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK1287134T3 (da) Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DE60118359D1 (de) Humanische pellino-polypeptide
ATE283368T1 (de) Für die glutamatabhängigen chloridkanäle kodierende dna
WO2000063415A8 (en) Dna encoding the human vanilloid receptor vr1
ATE384739T1 (de) Für den menschlichen vanilloid-rezeptor vr3 kodierende dns
DK1218491T3 (da) DNA kodende for en human 5-HT3-C-underenhed af 5-HT3-serotoninreceptoren
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
FR2770853B1 (fr) Gene codant pour la thanatine, vecteur le contenant et plantes transformees obtenues resistantes aux maladies
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
NO991227L (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
WO2000071741A3 (en) Dna encoding a human subunit of the 5-ht3 serotonin receptor
FR2722209B1 (fr) Recepteur opioide kappa humain, acides nucleiques et utilisations
WO2003040343A3 (en) Polynucleotide and polypeptide sequences of canine cathepsin s
WO2003040396A3 (en) Polynucleotide and polypeptide sequences of monkey cathepsins
ATE366261T1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
MY143222A (en) Expression vector for animal cell
ATE224730T1 (de) Mittel zur behandlung von pigmentierungsstörungen